Bristol-Myers Squibb Company (BRM DU) stock market data APIs
€54.4678
0.02(0%)
as of September 11, 2026
Try our APIs with
free plan!
Bristol-Myers Squibb Company Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for BRM.DU.
Prev. Close
54.4678
Open
54.4828
High
54.5299
Low
54.4512
52 wk Range
35.3759-59.99
Market Cap
110 771 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Bristol-Myers Squibb Company data using free add-ons & libraries
Get Bristol-Myers Squibb Company Fundamental Data
Bristol-Myers Squibb Company Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Bristol-Myers Squibb Company Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Bristol-Myers Squibb Company News
New
MRK Banks on Growing Pipeline & New Drugs to Offset Keytruda LOE
Merck MRK is relying on a growing pipeline and an expanding portfolio of newer medicines, including acquired assets, to offset the eventual impact of the loss of exclusivity (LOE) for its blockbuster ...
Bristol Myers’ Cancer Therapy Win Strengthens its Oncology Pipeline
Bristol-Myers Squibb Company (NYSE:BMY) said its experimental CAR-T cell therapy, arlocabtagene autoleucel (arlo-cel), met the main goal of a mid-stage trial in patients with advanced multiple myeloma...
Bristol Myers Squibb (BMY) Declines More Than Market: Some Information for Investors
In the latest close session, Bristol Myers Squibb (BMY) was down 1.02% at $63.75. The stock fell short of the S&P 500, which registered a loss of 0.59% for the day. Elsewhere, the Dow saw a downswing ...
Revolution Medicines Got a ‘Miracle’ Cancer Drug Approval. Wall Street Wants More.
Fresh off a regulatory victory for its groundbreaking cancer drug, Revolution Medicines could capture even more of the oncology market. Continue Reading
Get Bristol-Myers Squibb Company fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
